# Matthew ‘Oki’ O’Connor

> Matthew ‘Oki’ O’Connor is a startup investor at Cyclarity Therapeutics. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cyclarity Therapeutics](https://shizune.co/investors/profile/underdog-pharmaceuticals)
- Last updated: Aug 2026

Matthew ‘Oki’ O’Connor is a startup investor at Cyclarity Therapeutics.

## About Cyclarity Therapeutics

VC Fund · Mountain View, United States

Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis,hypercholesterolemia, heart failure, and macular degeneration.Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.

2 contacts available at Cyclarity Therapeutics.

| Name | Title | Profile |
| --- | --- | --- |
| Matthew ‘Oki’ O’Connor | Co-Chief Executive Officer and Co-founder | https://shizune.co/investors/profile/matthew-oki-o-connor-131c |
| Michael Kope | Co-Chief Executive Officer and Co-founder | https://shizune.co/investors/profile/michael-kope |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co